In order to tailor the site to your needs, please click the button that relates best to you.
So long as you have cookies enabled you will only need to do this once. However, you can change your selection at any time using the dropdown navigation option above the CESPHN logo, top left.
This post is not the latest immunisation update and therefore may contain information or advice that is out of date. Please see our most recent update here.
The ATAGI advice on the introduction of Gardasil®9 in a 2-dose schedule under the school-based National Immunisation Program (NIP) was updated on 11 January 2022.
COVID-19 vaccine stock management and delivery delays
Has your COVID-19 vaccine delivery been delayed? Call CESPHN on 1300 986 991 option 7 for COVID-19 or email coronavirus@cesphn.com.au to access emergency Pfizer 12 years+ (Purple) vaccine supplies or notify us of excess vaccines available for redistribution.
COVID-19 vaccine in the severely immunocompromised
Latest recommendation for COVID-19 vaccine in the severely immunocompromised (17 Jan 2022):
Severely immunocompromised children aged 5 to 11 years are now recommended to receive a 3rd primary dose of COVID-19 vaccine, 2 to 4 months after their second dose.
People aged 18 years or older who received a 3-dose primary course are now recommended to receive a booster (4th) dose ≥ 4 months after their 3rd dose.
People receiving hormonal therapy alone or localised radiotherapy are not recommended to receive a 3rd primary dose.
Vaccines recognised for the purpose of travel to Australia
As of 17 January 2022, the TGA determined that two doses of Sputnik V (Gamaleya Research Institute) would be ‘recognised’ for the purpose of purpose of travel to Australia, in addition to the 4 currently recognised vaccines.
New: Web-based Clinical guidance for Covid-19 vaccine providers
Recently, ATAGI’s Clinical Guidance on the use of COVID-19 vaccines in Australia in 2021 has been converted to web-based content on the Department of Health’s website (previously a PDF document). It will continue to be updated by ATAGI as new evidence becomes available.
Have you completed the relevant training for vaccinating 5 to 11 year old children?
Immunisation providers must complete the mandatory training Pfizer (Comirnaty) Paediatric (5 to <12 Years) COVID-19 Vaccine Training Module before vaccinating paediatric groups as doses are different from adolescents and adults.
Submit your AIR forms online using the upload function in HPOS
From 31 January 2022, the following Australian Immunisation Register (AIR) forms \will no longer be accepted if sent by email, mail or fax: Immunisation medical exemption (IM011), Immunisation history (IM013), and Immunisation encounter (IM018).
The AIR forms will only be accepted if submitted online in Health Professional Online Services (HPOS), using the form upload function in HPOS Messages. This function allows you to securely send messages with forms and supporting documents directly to AIR. See How to use HPOS features.
Join the latest COVID-19 vaccine live stream update for GPs. The panel will provide latest key updates and answer participants’ questions live about the COVID-19 vaccine rollout.
There are 4 different COVID-19 vaccines available for use in Australia. The below tools can assist with managing the different storage conditions and expiry requirements.
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
Immunisation weekly update – 1 February 2023 Childhood immunisation overdue reports CESPHN is inviting general practices to sign up to receive a regular report extracted on your behalf from the Australian Immunisation Register (AIR) which is specific to your practice. This report contains all children aged 0-5 living in the CESPHN region…
Australian Digital Health Agency (ADHA) digital health webinars Implementing MyHealth Record Policies in your organisation Thu 9 Feb 23, 12.30-1.00 pm – learn how to implement and maintain a My Health Record Security and Access policy in your organisation. Understand the importance of the Responsible Officer (RO) and Organisational Maintenance…
UNSW research – Palliative care and intellectual disability A research team led by Professor Julian Trollor at the Department of Developmental Disability Neuropsychiatry, UNSW Sydney, aims to design, implement, and evaluate a new palliative care service for people with intellectual disability. This is important because people with intellectual disability often…
GP support needed: Shared e-Care plan study for follow-up of colorectal and breast cancers This research evaluates shared care using a new interactive e-care plan being implemented through cancer services in Prince of Wales and St George public and private hospitals. Through the e-care plan GPs, cancer specialists and patients…
Seeking GP insight for HealthPathways Sydney improvement project Since its launch in March 2014, the HealthPathways Sydney program has developed nearly one thousand clinical HealthPathways and referral resources. The HealthPathways Sydney team are currently investigating how to make our processes for reviewing and updating content more efficient; ensuring that pathway…
Future of Home & Community Care Hybrid Conference The new Support at Home program and broader sector-wide reforms will have a significant impact on the way that Home and Community Care services are delivered and funded. You may have many questions over what the final model will look like, and…